Trial Profile
Single-dose study of PEG interferon beta-1a and interferon beta-1a in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Aug 2011
Price :
$35
*
At a glance
- Drugs Peginterferon beta-1a (Primary) ; Peginterferon beta-1a (Primary) ; Interferon beta-1a
- Indications Multiple sclerosis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Biogen Idec
- 16 Jun 2011 Results published in the Journal of Clinical Pharmacology, in combination with results from a phase Ib study (see 180385).
- 05 Nov 2010 New trial record.